International

International

Eric Blicker, MA CCC-SLP.D BCS-SDecember 21, 2021

InternationalRehabilitation

Gabriela Constantinescu, PhD, R.SLP, S-LP(C)October 4, 2021

International

Ed Bice, M.Ed., CCC-SLPJuly 26, 2021

InternationalRehabilitation

Gabriela Constantinescu, PhD, R.SLP, S-LP(C)June 14, 2021

InternationalRehabilitationTreatment

Leticia FreixoFebruary 16, 2021

InternationalPediatric

Ena Heimdahl, MAApril 28, 2019

AnatomyAssessmentEvidence Based PracticeInstrumental AssessmentInternational

Anna Miles, PhDNovember 29, 2016

AssessmentInstrumental AssessmentInternational

Catriona Steele, Ph.D., CCC-SLP, BCS-SJuly 20, 2016

InternationalPediatric

Ena Heimdahl, MAApril 5, 2016

InternationalPediatric

Ena Heimdahl, MAMarch 30, 2016

Continuing EducationInternational

Rinki Varindani Desai, M.S.CCC-SLPMarch 20, 2016

AssessmentInternationalTelepracticeTreatment

Elizabeth WardDecember 9, 2015

AssessmentInstrumental AssessmentInternationalRehabilitationTreatment

Emilia Michou Ph.D., PGDip, CertMRCSLTJanuary 8, 2015

Art & ScienceInternational

Luis Riquelme, PhD, CCC-SLP, BCS-SNovember 15, 2014

Leveraging the Data to Optimize Swallow and Cough Care in Cardiothoracic Intensive Care Units

Being Part of the Lung Squad: Management of Dysphagia in the Lung Transplant Population

A Paradigm Shift in Dysphagia Rehabilitation: Insights from Spinal Injury and Recovery

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

Type To Search

Leveraging the Data to Optimize Swallow and Cough Care in Cardiothoracic Intensive Care Units

Being Part of the Lung Squad: Management of Dysphagia in the Lung Transplant Population

A Paradigm Shift in Dysphagia Rehabilitation: Insights from Spinal Injury and Recovery

Legal links

Social media